United States · FDA National Drug Code directory
NADOLOL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72664-212_05f81151-3c12-9235-e063-6294a90af890
- Product NDC
- 72664-212
- Form
- TABLET
- Composition / generic term
- NADOLOL
- Labeler
- VGYAAN Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200630
- Source listing expiry
- 20261231
Source-listed ingredients
- NADOLOL — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (72664-212-01) · 72664-212-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →